218 related articles for article (PubMed ID: 27655844)
21. Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation.
Chen YJ; Chan DC; Chiang CK; Wang CC; Yang TH; Lan KC; Chao SC; Tsai KS; Yang RS; Liu SH
J Orthop Res; 2016 May; 34(5):791-800. PubMed ID: 26497299
[TBL] [Abstract][Full Text] [Related]
22. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
Shekhtman A; Ramasamy R; Schmidt AM
Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
[TBL] [Abstract][Full Text] [Related]
23. Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE.
Nielsen TB; Pantapalangkoor P; Yan J; Luna BM; Dekitani K; Bruhn K; Tan B; Junus J; Bonomo RA; Schmidt AM; Everson M; Duncanson F; Doherty TM; Lin L; Spellberg B
mBio; 2017 Aug; 8(4):. PubMed ID: 28830942
[TBL] [Abstract][Full Text] [Related]
24. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.
Wiedeman AE; Muir VS; Rosasco MG; DeBerg HA; Presnell S; Haas B; Dufort MJ; Speake C; Greenbaum CJ; Serti E; Nepom GT; Blahnik G; Kus AM; James EA; Linsley PS; Long SA
J Clin Invest; 2020 Jan; 130(1):480-490. PubMed ID: 31815738
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiological characteristics of preproinsulin-specific CD8+ T cells in subjects with juvenile-onset and adult-onset type 1 diabetes: A 1-year follow-up study.
Paul M; Badal D; Jacob N; Dayal D; Kumar R; Bhansali A; Bhadada SK; Sachdeva N
Pediatr Diabetes; 2018 Feb; 19(1):68-79. PubMed ID: 28488272
[TBL] [Abstract][Full Text] [Related]
26. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
[TBL] [Abstract][Full Text] [Related]
27. Preproinsulin specific CD8+ T cells in subjects with latent autoimmune diabetes show lower frequency and different pathophysiological characteristics than those with type 1 diabetes.
Sachdeva N; Paul M; Badal D; Kumar R; Jacob N; Dayal D; Bhansali A; Arora SK; Bhadada SK
Clin Immunol; 2015 Mar; 157(1):78-90. PubMed ID: 25597827
[TBL] [Abstract][Full Text] [Related]
28. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
[TBL] [Abstract][Full Text] [Related]
29. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M
J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802
[TBL] [Abstract][Full Text] [Related]
30. Activation of the receptor for advanced glycation end products and consequences on health.
Wautier MP; Guillausseau PJ; Wautier JL
Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
[TBL] [Abstract][Full Text] [Related]
31. Ligand binding affinity and changes in the lateral diffusion of receptor for advanced glycation endproducts (RAGE).
Syed A; Zhu Q; Smith EA
Biochim Biophys Acta; 2016 Dec; 1858(12):3141-3149. PubMed ID: 27720951
[TBL] [Abstract][Full Text] [Related]
32. [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for clinical applications].
Barbezier N; Tessier FJ; Chango A
Ann Biol Clin (Paris); 2014; 72(6):669-80. PubMed ID: 25486663
[TBL] [Abstract][Full Text] [Related]
33. Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.
Mikulkova Z; Praksova P; Stourac P; Bednarik J; Strajtova L; Pacasova R; Belobradkova J; Dite P; Michalek J
Cell Immunol; 2010; 262(2):75-9. PubMed ID: 20219185
[TBL] [Abstract][Full Text] [Related]
34. Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children.
Hedman M; Faresjö M; Axelsson S; Ludvigsson J; Casas R
Clin Exp Immunol; 2008 Sep; 153(3):360-8. PubMed ID: 18803760
[TBL] [Abstract][Full Text] [Related]
35. Impact of hyperglycemia and acute pancreatitis on the receptor for advanced glycation endproducts.
Zechner D; Sempert K; Genz B; Timm F; Bürtin F; Kroemer T; Butschkau A; Kuhla A; Vollmar B
Int J Clin Exp Pathol; 2013; 6(10):2021-9. PubMed ID: 24133579
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs in CD4(+) T cell subsets are markers of disease risk and T cell dysfunction in individuals at risk for type 1 diabetes.
Zhang Y; Feng ZP; Naselli G; Bell F; Wettenhall J; Auyeung P; Ellis JA; Ponsonby AL; Speed TP; Chong MM; Harrison LC
J Autoimmun; 2016 Apr; 68():52-61. PubMed ID: 26786119
[TBL] [Abstract][Full Text] [Related]
37. A cross talk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy.
Ma K; Xu Y; Wang C; Li N; Li K; Zhang Y; Li X; Yang Q; Zhang H; Zhu X; Bai H; Ben J; Ding Q; Li K; Jiang Q; Xu Y; Chen Q
Am J Physiol Endocrinol Metab; 2014 Dec; 307(12):E1153-65. PubMed ID: 25352436
[TBL] [Abstract][Full Text] [Related]
38. Glycated matrix up-regulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide.
Chang PC; Chien LY; Chong LY; Kuo YP; Hsiao JK
J Periodontal Res; 2013 Apr; 48(2):184-93. PubMed ID: 22924807
[TBL] [Abstract][Full Text] [Related]
39. Aberrant regulation of interleukin-12 receptor beta2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes.
Skarsvik S; Ludvigsson J; Vaarala O
Immunology; 2005 Feb; 114(2):287-93. PubMed ID: 15667574
[TBL] [Abstract][Full Text] [Related]
40. At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.
Glisic-Milosavljevic S; Waukau J; Jailwala P; Jana S; Khoo HJ; Albertz H; Woodliff J; Koppen M; Alemzadeh R; Hagopian W; Ghosh S
PLoS One; 2007 Jan; 2(1):e146. PubMed ID: 17206281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]